Related references
Note: Only part of the references are listed.External beam radiotherapy plus single-fraction high dose rate brachytherapy in the treatment of locally advanced prostate cancer
Ana Boladeras et al.
RADIOTHERAPY AND ONCOLOGY (2014)
A modelled comparison of prostate cancer control rates after high-dose-rate brachytherapy (3145 multicentre patients) combined with, or in contrast to, external-beam radiotherapy
Stephen A. Roberts et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials
Christopher R. King et al.
RADIOTHERAPY AND ONCOLOGY (2013)
GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update
Peter J. Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
Peter Grimm et al.
BJU INTERNATIONAL (2012)
Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer
Peter J. Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patients
Peter Agoston et al.
BRACHYTHERAPY (2011)
Five Year Results of a Randomized External Beam Radiotherapy Hypofractionation Trial for Prostate Cancer
A. Pollack et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
DERIVING PROSTATE ALPHA-BETA RATIO USING CAREFULLY MATCHED GROUPS, LONG FOLLOW-UP AND THE PHOENIX DEFINITION OF BIOCHEMICAL FAILURE
Richard Shaffer et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) Gy
Raymond Miralbell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
POD-07.01 Dose Escalation with High-Dose 3D-Conformal Radiotherapy (HD-3D-CRT) or Low-Dose 3D-Conformal Radiotherapy plus HDR Brachytherapy (LD-3D-CRT+HDR-B) for Intermediate-Or High-Risk Prostate Cancer: Higher PSA Control with Lower Toxicity
B. Guix et al.
UROLOGY (2011)
High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer
Daniel R. Zwahlen et al.
BRACHYTHERAPY (2010)
Treatment of Intermediate-or High-risk Prostate Cancer by Dose Escalation with High-dose 3D-conformal Radiotherapy (HD-3D-CRT) or Low-dose 3D-conformal Radiotherapy Plus HDR Brachytherapy (LD-3D-CRT+HDR-B): Early Results of a Prospective Comparative Trial
B. Guix et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Preliminary Report of a Randomized Dose Escalation Trial for Prostate Cancer using Hypofractionation
D. A. Kuban et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09
Anthony L. Zietman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Which α/β ratio and half-time of repair are useful for predicting outcomes in prostate cancer?
Philippe Nickers et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: A systematic review
Bradley R. Pieters et al.
RADIOTHERAPY AND ONCOLOGY (2009)
High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial
Peter J. Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
David P. Dearnaley et al.
LANCET ONCOLOGY (2007)
Is the α/β value for prostate tumours low enough to be safely used in clinical trials?
A. Dasu
CLINICAL ONCOLOGY (2007)
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate
JR Sathya et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Radical prostatectomy, external beam radiotherapy > 72 Gy, external beam radiotherapy <= 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer
PA Kupelian et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
How low is the α/β ratio for prostate cancer?
HB Kal et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer:: Implications for the α/β ratio
AE Nahum et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Share Paper
